FRIEDMAN, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 12.894
Totale 12.894
Nazione #
IT - Italia 12.894
Totale 12.894
Città #
Genova 8.509
Rapallo 1.699
Genoa 1.433
Vado Ligure 1.218
Bordighera 35
Totale 12.894
Nome #
Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients 234
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 194
Biliopancreatic diversion 163
Orbital swelling as a first symptom in breast carcinoma diagnosis: a case report 158
FIVE YEARS' EXPERIENCE WITH HICKMAN CATHETERS AS TEMPORARY ACCESS FOR HAEMODIALYSIS. 155
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. 155
Right portal vein thrombosis after splenectomy for trauma 136
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 136
Atypical ductal hyperplasia diagnosed at 11-gauge vacuum-assisted breast biopsy performed on suspicious clustered microcalcifications: could patients without residual microcalcifications be managed conservatively? 134
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes 134
Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment 129
How to limit lymphatic morbidity in breast cancer treatment 128
Tumescent anesthesia in skin- and nipple-sparing mastectomy: Results of a prospective clinical study 127
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 126
Comparison of local recurrence among early breast cancer patients treated with electron intraoperative radiotherapy vs hypofractionated photon radiotherapy an observational study 126
HERNIA REPAIR IN ELDERLY PATIENTS 125
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 125
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 123
Flat Epithelial Atypia: Comparison Between 9-Gauge and 11-Gauge Devices 123
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 121
Biliopancreatic diversion for obesity at eighteen years 121
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 120
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 119
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 114
The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases 113
Intraoperative digital breast tomosynthesis using a dedicated device is more accurate than standard intraoperative mammography for identifying positive margins 113
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 112
No Axillary Lymph Node Dissection in Breast Cancer Patients with Sentinel Lymph Node Micrometastasis 109
Ectopic breast cancer: case report and review of the literature. 109
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 109
BILIOPANCREATIC DIVERSION 108
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 108
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 108
Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up 107
In vivo evaluation of immunological status after biliopancreatic bypass. 105
Pregnancies in an 18-year follow-up after biliopancreatic diversion 101
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence 101
PROTEIN-MALNUTRITION AFTER BILIOPANCREATIC DIVERSION (BPD) 100
'Simple' form of Caroli's disease 99
liver morphology and function after biliopancreatic bypass 97
Tumor size-driven dose of intraoperative radiotherapy for breast cancer: 18 Gy versus 21 Gy 97
CHANGES OF BODY-COMPOSITION FOLLOWING BILIOPANCREATIC BYPASS (BPB) 97
[Behavior of plasma insulin and GIP in obese patients subjected tobiliopancreatic bypass]. 95
AUTOLOGOUS BLOOD TRANSFUSION IN BILIOPANCREATIC BYPASS SURGERY. A PRELIMINARY REPORT. 93
CHANGES OF GASTRIC ACID SECRETION AFTER PARTIAL BILIOPANCREATIC BYPASS. 92
Biliopancreatic diversion. 92
Biliopancreatic bypass. 89
The role of sentinel lymph node biopsy in patients with B5C breast cancer diagnosis 89
SURGICAL REVISION OF BILIOPANCREATIC DIVERSION (BPD) 88
Magnetic resonance imaging of breast cancer: Does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing? 87
CHANGES IN PLASMA GUT HORMONES AFTER BILIOPANCREATIC BYPASS FOR OBESITY. A PRELIMINARY REPORT. 86
URINARY OXALATE EXCRETION AFTER BILIOPANCREATIC BYPASS. 86
THE EFFECT OF BILIOPANCREATIC DIVERSION ON SERUM CHOLESTEROL 86
Partial and total biliopancreatic bypass in the surgical treatment of obesity. 84
Liver morphology and function in 500 morbidly obese patients 84
Biliary ileus. Considerations in surgical strategy 84
In vivo evaluation of postoperative immunosuppression by means of Multitestsystem. 83
Hepatic effects of biliopancreatic bypass 83
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study. ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 83
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters 83
[Urinary excretion of oxalate after bilio-pancreatic bypass for obesity]. 82
BODY COMPOSTION IN MASSIVELY OBESE PATIENTS 82
EATING HABITS FOLLOWING BILIOPANCREATIC DIVERSION (BPD) 82
The use of bioelectrical impedance analysis for monitoring body composition changes during nutritional support. 81
LA CHIRURGIA MAGGIORE DELLA MAMMELLA IN DAY-SURGERY: RAZIONALE E NOSTRA ESPERIENZA 79
Behavior of plasma gastrin in obese subjects subjected to biliopancreatic bypass [Comportamento della gastrina plasmatica in soggetti obesi sottoposti a bypass biliopancreatico] 79
In vivo evaluation of cell mediated immunity by means of Mulitest system 79
Surgical management of acute pancreatitis in Italy: Lessons from a prospective multicentre study 79
LA DIVERSIONE BILIOPANCREATICA A SEDICI ANNI 78
Etiological factors of protein malnutrition after biliopancreatic diversion. 78
[Protein absorption after bilio-pancreatic bypass for obesity]. 78
[2 cases of death caused by hepatic insufficiency after jejuno-ileal bypass forobesity]. 78
effect of biliopancreatic diversion on serum choestero.l 78
Implant-Based Breast Reconstruction Using a Polyester Mesh (Surgimesh-PET): A Retrospective Single-Center Study 78
EVOLUTION OF BILIOPANCREATIC BYPASS. 77
Intraoperative radiotherapy (IORT) in relapsed breast cancer: a possibility for a new conservative therapy 77
THE INCIDENCE OF PROTEIN MALNUTRITION (PM) AFTER "AD HOC STOMACH" (AHS) BPD CAN BE MINIMIZED, WHILE PRESERVING GOOD WEIGHT LOSS RESULTS, BY ELONGATING ALIMENTARY LIMB (AL) IN SELECTED PATIENTS 77
A two-step selection of breast cancer patients candidates for exclusive IORT with electrons: a mono-institutional experience 77
IN VIVO EVALUATION OF IMMUNOLOGICAL STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 76
[Automated determination of total nitrogen in urine and feces]. 76
BODY COMPOSITION AFTER "VERY LITTLE STOMACH" BILIOPANCREATIC BY¬PASS 75
In situ ductal carcinoma of the breast: current status and our experience 75
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected tobiliopancreatic bypass]. 75
[Evaluation of body composition in obese subjects]. 75
Comportamento dell'insulina e del GIP plasmatici in soggetto obesi sottopost a bypass biliopancratico 75
[Absorption of vitamin B 12 after biliopancreatic bypass for obesity]. 75
Pregnancy following surgical treatment of morbid obesity. Review of literature and our experience with biliopancreatic diversion [Gravidanza dopo terapia chirurgica dell'obesità. Revisione bibliografica e nostra esperienza con la diversione biliopancreatica] 75
Predictive factors of non-sentinel lymph node involvement in patients with invasive breast cancer and sentinel node micrometastases 74
[Behavior of plasma pancreatic polypeptides and motilin in obese patientssubjected to biliopancreatic bypass]. 73
TIMING OF SURGERY RELATED TO MENSTRUAL CYCLE AND PROGNOSIS OF PREMENOPAUSAL WOMEN WITH BREAST CANCER. 73
No ink on ductal carcinoma in situ: A single centre experience 73
Clinical decision-making in atypical and suspicious categories in fine-needle aspiration cytology of the breast 72
cHANGES IN BODY COMPOSITION FOLLWOING BILIOPANCREATIC BYPASS (BPB) 72
BONE HISTOMORPHOMETRY FOLLOWING BILIOPANCREATIC DIVERSION (BPD) 71
PARTIAL AND TOTAL BYPASS IN THE SURGICAL REATMENT OF OBESITY. 71
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 71
COMPOSIZIONE CORPOREA IN PAZIENTI OBESI 69
INTESTINAL ADAPTION FOLLOWING BILIOPANCREATIC BYPASS. 69
Surgical revision of biliopancreatic bypass. 69
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 69
Totale 9.808
Categoria #
all - tutte 42.831
article - articoli 41.355
book - libri 0
conference - conferenze 230
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.246
Totale 85.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.110 0 0 0 0 0 261 448 121 202 621 350 107
2020/2021943 81 65 121 88 15 107 72 41 132 61 81 79
2021/20222.011 28 166 131 372 86 114 142 424 87 159 59 243
2022/20232.053 221 112 18 189 331 376 26 178 312 16 240 34
2023/20241.000 57 126 15 134 80 202 34 61 44 40 71 136
2024/20251.344 94 222 89 180 462 297 0 0 0 0 0 0
Totale 13.040